Articles
Doctor taking prescription off shelf
Direct-to-patient access: Five questions pharma must answer
Direct-to-patient models are reshaping commercialization strategy. Explore key considerations around patient access, operational readiness, scalability, and DTP strategy in this Pharmaphorum interview with Acumetis.
Read More
Articles
World Orphan Drug congress USA 2026 logo on background
Meet Acumetis at WODC US!
Meet Acumetis at WODC US 2026 in Boston. Connect with our GVA team and explore the evolving challenges of pricing, reimbursement, and patient access for orphan and rare disease therapies.
Read More
Case Studies
Top down view of a river next to a shore
Optimizing Clinical Endpoints for Phase III Design
A Medical Affairs case study demonstrating how evidence review and stakeholder insight were used to refine clinically meaningful endpoints and support Phase III trial design and regulatory dialogue.
Read More
Case Studies
Top down view of a river tributaries on sand
How to achieve HTA submission success for rare disease therapies
A case study illustrating how an evidence‑led, strategically aligned HTA approach can address uncertainty and strengthen submissions for rare disease therapies.
Read More
Articles
Abstract image of different shaped holes in building
Generative AI in publications development: Innovation with oversight
Explore how generative AI can enhance medical publication development with the oversight, rigor, and scientific integrity required by Medical Affairs teams.
Read More
Articles
Doctor showing patient something on a tablet
From approval to patient access: How oncology pharmacy is shaping real-world delivery 
Explore how oncology pharmacy services are shaping real-world delivery and patient access, and why operational readiness is critical beyond HTA approval.
Read More
Articles
Model Builder
Assessing payer ready economic model quality: Acumetis Model Builder vs AI
Can AI support HTA-ready economic models? Compare AI and Model Builder across reproducibility, transparency, and payer readiness.
Read More
Articles
Asembia logo on background
Meet Acumetis at Asembia ASX26
Acumetis (formerly Herspiegel) will be attending Asembia AXS Summit 2026, widely recognized as the epicenter of the specialty pharmacy industry. With more than 8,000 attendees—many of whom are senior decision-makers—Asembia...
Read More
Articles
Zurich MAPS EMEA 2026 logo on background
Meet Acumetis at MAPS EMEA 2026
Meet Acumetis at MAPS EMEA 2026 in Zurich. Connect with our Medical Affairs team and explore approaches to scientific strategy, evidence, and execution.
Read More